BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/18/2024 9:29:50 AM | Browse: 205 | Download: 843
 |
Received |
|
2024-03-01 08:46 |
|
Peer-Review Started |
|
2024-03-01 08:46 |
|
First Decision by Editorial Office Director |
|
2024-04-09 04:46 |
|
Return for Revision |
|
2024-04-09 04:46 |
|
Revised |
|
2024-04-23 09:38 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-04-30 02:33 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-04-30 05:31 |
|
Articles in Press |
|
2024-04-30 05:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-06-03 05:58 |
|
Publish the Manuscript Online |
|
2024-06-18 09:29 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Dermatology |
| Manuscript Type |
Translational Research |
| Article Title |
Exploring the potential mechanism of WuFuYin against hypertrophic scar using network pharmacology and molecular docking
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shu-Yang Zhang, Song-Xue Guo, Lei-Lei Chen, Jia-Yan Zhu, Ming-Sheng Hou, Jia-Ke Lu and Xue-Xiang Shen |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| 2022 Shaoxing City Health Science and Technology Program (Health Science and Technology Program) |
No. 2022KY050 |
|
| Corresponding Author |
Xue-Xiang Shen, MD, Associate Chief Physician, Department Of General Surgery, Shaoxing Hospital of Traditional Chinese Medicine, No. 641 Renmin Middle Road, Yuecheng District, Shaoxing 312000, Zhejiang Province, China. zsyzsy0522@163.com |
| Key Words |
WuFuYin; Hypertrophic scar; Network pharmacology; Molecular docking; Enrichment analysis |
| Core Tip |
This study identified 8 hub genes [CKD2, ABCC1, MMP2, MMP9, glycogen synthase kinase 3 beta (GSK3B), PRARG, MMP3, and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma (PIK3CG)] and five key compounds (MOL004941, MOL004935, MOL004866, MOL004993, and MOL004989) in the WuFuYin (WFY) as an effective treatment for hypertrophic scar (HTS). We found that PI3K-Akt pathway played a crucial role in the WFY. The results of molecular docking showed that GSK3B and cyclin dependent kinase 2 affected HTS through targeting MOL004941, MOL004989, and MOL004993. |
| Publish Date |
2024-06-18 09:29 |
| Citation |
Zhang SY, Guo SX, Chen LL, Zhu JY, Hou MS, Lu JK, Shen XX. Exploring the potential mechanism of WuFuYin against hypertrophic scar using network pharmacology and molecular docking. World J Clin Cases 2024; 12(18): 3505-3514
|
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i18/3505.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i18.3505 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
